Zender L, Malek N P
Medizinische Klinik I (Gastroenterologie, Hepatologie und Infektiologie), Medizinische Universitätsklinik, Eberhard Karls Universität Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Deutschland.
Internist (Berl). 2016 Dec;57(12):1191-1205. doi: 10.1007/s00108-016-0128-5.
Cholangiocellular carcinoma (CCA) is the second most frequent primary liver carcinoma and is an aggressive tumor, which is mostly diagnosed in advanced stages. The overall survival is poor. Histpathological analysis of tumor biopsies or cytological analysis of biliary brushings can be used to confirm the diagnosis. A differentiation is made between distal, perihilar and intrahepatic CCA. The anatomical position determines the diagnostic and therapeutic strategy. Before diagnostic or therapeutic measures are undertaken it is essential to resolve biliary obstruction via endoscopic stenting or percutaneous biliary drainage. Depending on the tumor stage curative treatment options comprise radical surgical resection with hepaticojejunostomy or in selected cases liver transplantation. For intrahepatic or distal CCA liver transplantation is not indicated. In the palliative setting systemic chemotherapy with gemcitabine and cisplatin leads to a significant improvement in survival time.
胆管细胞癌(CCA)是第二常见的原发性肝癌,是一种侵袭性肿瘤,大多在晚期被诊断出来。总体生存率较差。肿瘤活检的组织病理学分析或胆汁刷检的细胞学分析可用于确诊。CCA可分为肝外胆管远端、肝门周围和肝内胆管细胞癌。解剖位置决定了诊断和治疗策略。在采取诊断或治疗措施之前,通过内镜支架置入术或经皮胆道引流解除胆道梗阻至关重要。根据肿瘤分期,根治性治疗方案包括肝空肠吻合术的根治性手术切除,或在某些选定病例中进行肝移植。肝内或肝外胆管远端的CCA不适合进行肝移植。在姑息治疗中,吉西他滨和顺铂的全身化疗可显著延长生存时间。